This study aimed to address the health disparities of HIV cases in black men residing in Brooklyn by visiting sites where they are more likely to congregate, like barber shops, and presenting a culturally tailored HIV curriculum to them.

Olusola Adeonigbagbe, MPH; Brittney Vincent, MPH; Kenya Kirkman, MPH; Faven Araya, MPH

Olusola Adeonigbagbe, MPH

For over 30 years, the New York State Department of Health and New York State Department of Corrections and Community Supervision have worked together on this study to elucidate the burden of HIV among individuals facing incarceration. This double-blinded study highlights factors related to the receipt of a seropositive HIV antibody test result and shows descriptive trends of these factors throughout time. While more collaboration is needed to monitor these factors, public health entities can use the current information for interventions and initiatives targeting individuals who shoulder the highest burden of HIV.

Cameron Dowd-Sivigny, MPH; Daniel Frederick, MPH; Wendy Patterson, MPH; John Morley, MD; Deepa Rajulu, MS

Cameron Dowd-Sivigny, MPH

Amida Care (AC) is a Medicaid Special Needs Health Plan that serves over 9,000 patients in New York City, of which 70% are People With HIV. In June 2022, AC's clinical pharmacy service established a Viral Load Suppression ARV Refill (VLSAR) Initiative that takes an integrated comprehensive approach to address adherence concerns and improvement towards viral suppression. For 2023, 121 members were identified and evaluated for VLSAR, of which 52% achieved a viral load result of <1000 after pharmacist intervention and provider engagement from VLSAR. For 2024, 105 members were identified for VLSAR and 47 (45%) patients achieved a viral load result of <1000 after pharmacist intervention and provider engagement. 32 (30%) patients experienced a change of ARV regimen after intervention. Provider responses were received for 92 patients from the original cohort.

Chris Milan, PharmD, AAHIVP; Vera Antonios, MD; Hemant Lanjewar, MHSA

Chris Milan, PharmD, AAHIVP

The poster displays the components of a COVID-19 prevention and mitigation project in homeless shelters in the State through partnerships among AIDS Institute, University of Rochester Center for Community Practice (UR-CCP) and CARES of NY. UR-CCP conducted observations and needs assessments at 20 homeless service sites, which informed the development of an interactive online toolkit to support each shelter’s unique needs. Interactive workbooks were designed for shelters to optimize their alignment with CDC guidance to prevent and mitigate COVID-19 based on each shelter’s specific building and operational characteristics.

Juhua Wu, MA, PCC; Mary Adams, RN, MPH; Karissa Hannon, MBA, MSBA; Cindy Ravida, Sherry Piscitella

Mary Adams, RN, MPH; Karissa Hannon, MBA, MSBA

The Clinical Education Initiative (CEI) Sexual Health Center of Excellence provides STI and sexual health-related clinical education and access to STI experts via the CEI Line as part of an effort to end the STI epidemic. The CEI Line provides NYS clinicians and health departments access to infectious diseases expertise and advice on STI cases. This poster reviews CEI Line call data from 2014-2024 to show the marked increase in call volume over the ten-year period, highlighting a substantial increase in calls related to syphilis following several New York State Department of Health Alerts/Advisories related to STIs.

Jessica L. VanScott, MPH; Marguerite A. Urban, MD; Daniela E. DiMarco, MD, MPH

Jessica L. VanScott, MPH

Syphilis and congenital syphilis rates are rising in New York State. The New York State Department of Health Office of Sexual Health and Epidemiology and the Clinical Education Initiative Sexual Health Center of Excellence partnered to create the Congenital Syphilis Prevention Program (CSPP). The CSPP works to provide community providers and Health Department staff timely clinical guidance and support follow-up, for cases of syphilis during pregnancy to help prevent congenital syphilis in New York State.

Daniela E. DiMarco, MD, MPH; Melinda Godfrey, FNP-C, MBA; Geoffrey Weinberg, MD; Marguerite A. Urban, MD

Daniela E. DiMarco, MD, MPH

This study investigated repeat positivity of chlamydia in New York State to help focus public health resources and interventions and improve the sexual health of our state’s population.

Salvatore Currenti, MPH; Thomas O’Grady, PhD, MPH; Srikanth Bomma, MS; Namratha Gurram, MBBS, MPH; Wilson Miranda, MPH; Rachel Hart-Malloy, PhD, MPH

Salvatore Currenti, MPH

Polypharmacy is a growing concern in people aging with HIV (PAWH). This intervention integrated clinical pharmacists into a comprehensive primary care clinics for persons living with HIV, with a focus on PAWH. Clinical pharmacists participated in clinic visits and conducted asynchronous chart reviews with the goal of providing patient education, ensuring medication adherence, avoiding drug-drug interactions, and reducing polypharmacy.

Sandra Tarpey, NP; Eileen Hagan, LPN; Michael O’Shea, PharmD; Jessica Lewis PharmD; Darko Todorov, PharmD, BCPS; Nicholas Feola, PharmD, BCIDP; Rebecca Glassman MD

Sandra Tarpey, NP

The presentation highlights the importance of having access to additional methods of HIV prevention through the form of Long-Acting Injectables. It has helped to increase adherence and encourages frequent STI testing among vulnerable populations in Brooklyn.

Lauren Pitt; Yasbert Soberal Perez; Caitlyn Howell; Stephanie Alvarez, MPH; Sarah Rosenwald; Carlos Duran; Marilyn Rodriguez; Sara Armstrong, FNP; Anne Mattson, MPH; Josh Klein; Caroline Carnevale, DNP; Waldys Cruz LMSW; Jason Zucker, MD; Peter Gordon, MD

Lauren Pitt, MPH; Yasbert Soberal Perez

This study assessed the relationship between social vulnerability and demographic characteristics on time to antiretroviral initiation and HIV viral suppression among persons newly diagnosed with HIV (PNDWH). Overall, ARV initiation within seven days of HIV diagnosis was associated with viral suppression within 90 days of diagnosis. When stratified by Social Vulnerability Index SVI quartiles, the relationship between time to ARV initiation and viral suppression was similar for individuals in the most (RR=1.56 (95% CI:1.31-1.87)) and least (RR=1.58 (95% CI:1.28-1.95)) vulnerable quartiles. Individuals assigned female sex-at-birth, those with a history of injection drug use, newly diagnosed individuals who were non-Hispanic Black, and those living in the Long Island and Hudson Valley Ryan White Regions were less likely to start treatment within seven days of diagnosis when compared to their comparison groups.

Sarah E. Macinski, MS; Rebecca L. Deamer, MSW; Deepa T. Rajulu, MS; Carol-Ann E. Swain, PhD

Sarah E. Macinski, MS; Rebecca L. Deamer, MSW